Company / Shareholders' Equity
Teladoc Health, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.4B
FY2025
5-year range
$1.4B / $16.0B
FY2021-FY2025
Trend
-7.1%
vs FY2024
Sector context
#73 of 166
Health Care
What the data says
At $1.4B, Teladoc Health, Inc.'s shareholders' equity ranks #73 of 166 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $231M in FY2016 to $16.0B in FY2021.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of -38.6%.
Declined from $2.3B to $1.4B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -15.6%
- 5-Year CAGR
- -38.6%
- 10-Year CAGR
- -
Sector benchmark
#73 of 166 in Health CareTop 44% of 166This company $1.4B Sector average $5.3B
▼
-73.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -38.6%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 7.1% year-over-year.
- Ranks #73 out of 166 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | -7.1% |
| FY2024 | $1.5B | -35.9% |
| FY2023 | $2.3B | +0.8% |
| FY2022 | $2.3B | -85.6% |
| FY2021 | $16.0B | +1.0% |
| FY2020 | $15.9B | +1466.4% |
| FY2019 | $1.0B | +0.1% |
| FY2018 | $1.0B | +81.3% |
| FY2017 | $558.9M | +142.1% |
| FY2016 | $230.9M | +29.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026